Veradermics, Incorporated ($MANE)
Filing Information
| Accession Number | 0001628280-26-005904 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 6, 2026 |
| Document Date | Feb 3, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
8,277,877
Total Value
$18,275,000.00
P&L
+158.5% (+$28,960,924.27)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 5, 2026 | Conversion | 1,236,631 | โ | โ | 1,236,631 | Indirect | See Footnote | View Details | |
Director | Common Stock | โ | Feb 5, 2026 | Conversion | 1,171,121 | โ | โ | 2,407,752 | Indirect | See Footnote | View Details | |
Director | Common Stock | โ | Feb 5, 2026 | Conversion | 1,171,121 | โ | โ | 1,171,121 | Indirect | See Footnote | View Details | |
Director | Common Stock | โ | Feb 5, 2026 | Purchase | 192,647 | $17.00 | $3,274,999.00 | 2,600,399 | Indirect | See Footnote | View Details | |
Director | Common Stock | โ | Feb 5, 2026 | Purchase | 882,353 | $17.00 | $15,000,001.00 | 2,053,474 | Indirect | See Footnote | View Details | |
Director | Series B Convertible Preferred Stock | Derivative | Feb 5, 2026 | Conversion | 1,236,631 | โ | โ | 0 | Indirect | See Footnote | View Details | |
Director | Series C Convertible Preferred Stock | Derivative | Feb 5, 2026 | Conversion | 1,171,121 | โ | โ | 0 | Indirect | See Footnote | View Details | |
Director | Series C Convertible Preferred Stock | Derivative | Feb 5, 2026 | Conversion | 1,171,121 | โ | โ | 0 | Indirect | See Footnote | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Feb 3, 2026 | Grant/Award | 45,131 | $0.00 | $0.00 | 45,131 | Direct | โ | View Details |